REG - Sunplus Technology - 3rd Quarter Results

Sunplus Technology CoAnnouncement

13/11/2019 10:10

RNS Number : 2657T
Sunplus Technology Co Limited
13 November 2019
 


Sunplus Technology Company Limited
Consolidated Balance Sheets
Ended September 30, 2019*
(In Thousands of New Taiwan Dollars)
 



Assets


Amount


Liabilities & Shareholders Equity


Amount




Cash & Equivalent


2,864,121


Current Liabilities


1,303,417




Financial assets at fair value through profit or loss-current 


1,049,450


Non-Current Liabilities


589,877




Accounts & Notes receivable


998,418


Total Liabilities


1,893,294




Other Receivable


83,497


Equity attributable to owners of the parent








Inventories


777,081


Capital stock


5,919,949




Other current assets


225,677


Shares to be issued








Total Current Assets


5,998,244


Capital surplus


595,958












Appropriated as legal reserve


1,942,388




Financial assets at fair value through profit or loss - non-current


842,322


Appropriated as special reserve


308,452




Financial assets at fair value through other comprehensive income t - non-current


214,451


Unappropriated earnings (deficit)


(267,676)




Investments accounted for using the equity method


713,148


Others


(195,246)




Property, plant and equipment


2,009,142


Treasury Stock


(63,401)




Right-of-use asset


242,751


Total equity attributable to owners of the parent


8,240,424




Investment properties


1,095,178












Intangible Assets-Net


184,021


Non-Controlling Interests


1,372,651




Deferred tax assets


30,980


Total Shareholders¡¦ Equity


9,613,075




Other Non-Current Assets


176,132












Total Non-Current Investments


5,508,125












Total Assets


        11,506,369


Total Liabilities & Shareholders' Equity


11,506,369







 
Sunplus Technology Company Limited
Consolidated Statements of Income
From January 1 to September 30, 2019 and 2018
(In Thousands of New Taiwan Dollars, Except Earnings per share) 



Unit: NT$K, Except EPS


2019


2018


YoY




Net sales


$4,188,646


$4,771,200


(12.21)




Cost


2,379,656


2,889,576


(17.65)




Gross Profit


1,808,990


1,881,624


(3.86)




  Marketing Expense


209,424


229,031


(8.56)




  General& Administrative Expense


372,162


392,391


(5.16)




R&D Expenses


1,122,046


1,338,984


(16.20)




Expected credit losses


183


-


-




Other operating income(Expense)


116


11


954.55




Total operating income (expense)


105,291


(78,771)


(233.67)




Total non-operating income (expense)


97,498


303,997


(67.93)




Income(loss) before income tax from continued operating units


202,789


225,226


(9.96)




Income tax expense


52,755


50,100


5.30




Consolidated Net Income


150,034


175,126


(14.33)




Consolidated Net Income

Attributable To Shareholders of the parent


$14,717


$66,209


(77.77)




Consolidated Earnings Per Share NT$ Attributable To Shareholders of the parent*


$0.03


$0.11







* Based on outstanding 588,434,923 shares on 2019/09/30




Sunplus Technology Company Limited
Consolidated Cash Flow Summary
From January 1 to September 30, 2019 and 2018
(In Thousand New Taiwan Dollars)
 



ITEM


2019


2018




Cash Flow in (out) from operating


250,431


(19,875)




Cash Flow in (out) from Investing


(18,211)


(390,457)




Cash Flow in (out) from Financing


(606,088)


(813,087)




Impact from Fx Change


2,268


5,143




Net Increase (Decrease) in Cash & Cash Equivalents


(371,600)


(1,218,276)




Cash & Cash Equivalents, Beginning of Period


3,235,721


4,156,277




Cash & Cash Equivalents, End of Period


2,864,121


2,938,001



 
 




Spokesman
Wayne Shen
Tel: +886-3-5786005 ext. 2350
E-mail: wayne@sunplus.com
 


 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
QRTGMMMMGFKGLZM